FutureChem Co.,Ltd (220100.KQ)

KRW 23100.0

(-0.86%)

Long Term Debt Summary of FutureChem Co.,Ltd

  • FutureChem Co.,Ltd's latest annual long term debt in 2023 was 2.61 Billion KRW , up 36.26% from previous year.
  • FutureChem Co.,Ltd's latest quarterly long term debt in 2024 Q2 was 2.14 Billion KRW , down 0.0% from previous quarter.
  • FutureChem Co.,Ltd reported annual long term debt of 1.92 Billion KRW in 2022, down -77.31% from previous year.
  • FutureChem Co.,Ltd reported annual long term debt of 8.47 Billion KRW in 2021, down -38.28% from previous year.
  • FutureChem Co.,Ltd reported quarterly long term debt of 2.64 Billion KRW for 2024 Q1, down -100.0% from previous quarter.
  • FutureChem Co.,Ltd reported quarterly long term debt of 2.61 Billion KRW for 2023 FY, up 36.26% from previous quarter.

Annual Long Term Debt Chart of FutureChem Co.,Ltd (2023 - 2016)

Historical Annual Long Term Debt of FutureChem Co.,Ltd (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 2.61 Billion KRW 36.26%
2022 1.92 Billion KRW -77.31%
2021 8.47 Billion KRW -38.28%
2020 13.72 Billion KRW 7.12%
2019 12.81 Billion KRW -57.27%
2018 29.99 Billion KRW 533.33%
2017 4.73 Billion KRW 0.0%
2016 - KRW 0.0%

Peer Long Term Debt Comparison of FutureChem Co.,Ltd

Name Long Term Debt Long Term Debt Difference
HLB Pharmaceutical Co., Ltd 988.75 Million KRW -164.959%
CMG Pharmaceutical Co., Ltd. 19.06 Billion KRW 86.258%
Celltrion Pharm, Inc. 4.33 Billion KRW 39.543%
Huons Global Co., Ltd. 66.94 Billion KRW 96.087%
DongKook Pharmaceutical Co., Ltd. 18.74 Billion KRW 86.028%
Enzychem Lifesciences Corporation 1.02 Billion KRW -155.59%
Humedix Co., Ltd. 1.75 Billion KRW -49.248%
Boditech Med Inc. 2.09 Billion KRW -24.756%
EuBiologics Co., Ltd. 2.8 Billion KRW 6.436%
Huons Co., Ltd. 58.35 Billion KRW 95.51%
BNC Korea Co., Ltd. 301.69 Million KRW -768.373%
AptaBio Therapeutics Inc. 13.56 Billion KRW 80.693%